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We have previously demonstrated that  the in vivo adoptive secondary antibody 
response to 2,4-dinitrophenyl-ovalbumin (DNP-OVA)1 in mice involves the synergistic 
activity of two distinct helper T  cells (1-4). One of these helper T  cells is specific for 
antigen and is thought to be major histocompatibility complex (MHC) restricted in 
its  activity.  It  requires  a  hapten-carrier  bridge  for  its  function and  is  absolutely 
required  for in  vivo anti-hapten  antibody responses  in  our system  (5). The  other 
helper T cell is also specific for antigen, but it does not require a hapten-carrier bridge 
(5). The second cell is not found in mice treated from birth with anti-/~ chain antibody, 
which led us to propose  that  this cell actually recognizes B cells  directly via their 
immunoglobulin (Ig)  receptor (4). Both helper T  cells are Lyt-l÷,2  -  (5). The action 
of the Ig-recognizing helper T  cell is transient in secondary antibody responses (1-4). 
Thus, its major effects are seen by 5-7 d  after boosting in adoptive transfer experi- 
ments, whereas by 10-12 d, its effects are no longer apparent. 
Experiments  examining the  expression  of a  vm'iety of Ig  idiotypes expressed  in 
response to different antigens are consistent with these findings (6-8).  In particular, 
experiments of Bottomly and co-workers (8, 9) have shown similar results in response 
to phosphorylcholine (PC), using the TEPC15 idiotype as a  marker for the function 
of Ig-recognizing T  cells. Furthermore, T  cells have been implicated in regulation of 
the isotype (10), allotype (11), charge (12), and affinity (13,  14) of antibody responses. 
We have proposed  (15) that all of these regulatory effects of helper T  cells upon 
antibody quality might be explained by Ig-recognizing helper T  cells.  Furthermore, 
we have suggested that the regulation of isotype might reflect the combined action of 
idiotype-specific helper T  cells and a restricted expression of idiotypes within certain 
isotypes, rather than regulation of Ig-isotype per se by such helper T  cells. 
To study such questions further in the response to the hapten DNP, we have here 
examined the time-course of expression of a  major idiotype during an in vivo anti- 
DNP antibody response. The genetics and immunochemistry of this idiotype (Id-460), 
found in the hapten-binding site of the DNP-binding myeloma protein MOPC 460, 
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have been  previously characterized in our laboratories (16-19).  The present experi- 
ments demonstrate several interesting points about Id-460. First, expression of Id-460 
in serum  varies markedly with  time after immunization,  often peaking very shortly 
after  boosting,  and  then  falling  rapidly.  Second,  the  anti-DNP  response  does  not 
parallel the expression of Id-460 in serum or in splenic plaque-forming cells (PFC). 
Third,  Id-460 expression shows no apparent  restriction to any of the isotypes (IgM, 
IgE, IgG2a, and IgG1) that we have measured. Rather, it would appear that Id-460  + 
clones  are  selectively  activated  early  in  secondary  anti-DNP  antibody  responses, 
possibly reflecting the activity of Id-460-specific helper T  cells. Later, Id-460- antibody 
predominates in this response. The genetic and cellular basis of this complex regulatory 
process will be examined in subsequent experiments. 
Materials  and  Methods 
Methods Previously Described.  Mice, antigens, myeloma proteins, antisera, immunizations, and 
radioimmunoassays for Id-460 and for anti-DNP antibody are all as previously described (19). 
Hemolytic Plaque Assa  5.  Spleen cells were assayed for direct, indirect, and specifc subclass 
anti-TNP PFC and for Id-460  + PFC by the Cunningham  and Szenberg modification of the 
Jerne plaque technique  (20).  Trinitrophenylated sheep erythrocytes (TNP-SRBC)  were pre- 
pared as follows: 1 ml packed SRBC (Colorado Serum Co., Denver, Colo.) were mixed with 4 
ml  10 mM trinitrobenzenesulfonic acid in phosphate-buffered saline (PBS), pH 7.4, at 37°C 
for 12 min and washed extensively with PBS (21).  TNP-SRBC were used as 1% suspension in 
RPMI 1640 medium buffered with 10 mM Hepes. Guinea pig serum, as a source of complement, 
was absorbed on TNP-SRBC to remove hemolytic antibody. All dilutions were done in RPMI 
1640. 
The use of various plaque-developing or -inhibiting antisera was required for quantitation 
of direct, indirect  (specific subclass), and  Id-460  + plaques. Direct plaques were inhibited by 
goat anti-mouse IgM antiserum. Anti-/z chain antibody was produced in a goat twice immunized 
with  100  /zg  MOPC  104E  in  complete  Freund's adjuvant  (CFA)  given  immediately after 
intravenous  injection of 5  mg  DEAE-purified mouse  Ig  (MIg).  Immunoelectrophoresis has 
shown  this antiserum  to  be specific for  mouse  IgM.  Nonspecific developing activities were 
eliminated by passage of the antiserum over a Sepharose immunoadsorbent column consisting 
of an IgA and a variety of IgG myeloma proteins (McPC 603,  MOPC 31c, MPC  11, FLOPC 
21, and MOPC  173). 
Developing antiserum for indirect PFC was obtained from rabbits immunized intraperito- 
neally with 1 mg of DEAE-purified MIg in CFA, followed 2 wk later by an intravenous boost 
of 4 mg alum-precipitated MIg. To remove nonspecific activity, the antiserum was absorbed on 
TNP-SRBC.  For development of individual IgG subclass PFC,  Richard Asofsky (National 
Institute of Allergy and  Infectious Diseases, National  Institutes of Health)  kindly provided 
rabbit anti-mouse IgG1, and anti-IgG2, antisera. Titrations were performed on all antisera to 
determine the dilution at which maximum activity was attained. 
Q uantitation of Id-460  + PFC was accomplished through  inhibition of anti-TNP PFC by 
rabbit anti-Id-460 antiserum. Immunization procedures and characterization of this antiserum 
are as previously described (19).  Genetic studies performed on  immune sera by competitive 
inhibition radioimmunoassays have shown this antiserum to be specific for Id-460 expression. 
Mice of the  IghV"  haplotype that  expresses VKI  light chains  can  make  Id-460.  For use  in 
plaquing studies, the antiserum was absorbed on a mixed myeloma sepharose column (consisting 
of McPC  603,  MOPC  31c,  MPC  11,  FLOPC  21,  and  MOPC  173) and  on  McPC  603- 
Sepharose. A titration of anti-Id-460 antiserum was performed at each time point plaqued to 
confirm specific inhibition of Id-460  + PFC. This antiserum did not  inhibit PFC specific for 
SRBC or PC (K. Bottomly, personal communication). Also, it was found to inhibit the plaque 
formation of MOPC 460  myeloma cells (40-90%) but not MOPC 315 cells (4%). 
The  accurate computation of IgM, IgG, IgM-Id-460  + and  IgG-Id-460  + TNP-PFC/spleen 
necessitated various controls to  identify background plaque  formation. Table I  illustrates a 
sample calculation of data obtained from a BALB.K mouse immunized with DNP-OVA. 1434  TRANSIENT  IDIOTYPIC  DOMINANCE 
TABLE  I 
Calculation  of PFC Data and Percent Id-460 + PFC 
Goat  Rabbit  Rabbit 
Test  anti-  anti-  anti-ld-  PFC/106 
IgM,  IgGl,  460, 
1:75  1:400  1:300 
Component of response measured 
1  -  -  -  86 
2  +  -  -  6 
3  +  -  +  22 
4  -  -  +  I0 
5  +  +  -  690 
6  +  +  +  60 
Direct PFC 
Suppression of direct PFC by anti-IgM; residual PFC due 
to contaminating developing antibody 
Development  of PFC  due  to  contaminating developing 
antibody in anti-Id-460 
Inhibition  of direct  PFC  by  anti-Id-460;  includes  PFC 
developed by anti-Id-460 
Indirect IgGl PFC 
Inhibition of IgG1 PFC by anti-Id-460 
Calculation of Id-460  ÷ direct and indirect PFC 
A.  IgM PFC  --  1  =  86 PFC/106 
B.  IgM Id-460  + PFC  =  1 -  (4-[3-2])  =  92 PFC/106 
C.  IgG1 PFC  =  5 -- 2  =  684 PFC/106 
D.  IgG, Id-460 + PFC  --  (5-2)-  (6-3)  =  646PFC/10 ~ 
B  92 
Percent Id-460 + IgM PFC -- ~  X  100% =  ~  X  100 =  100% 
D  =  646 ×  100 =  94%  Percent Id-460 + IgGl PFC  =  ~  X  100%  684 
Data from BALB.K day 5 secondary anti-TNP  PFC response to DNP-OVA. 
Results 
Levels of Id-460 and Anti-DNP Antibody Are Independently Regulated.  In the previous 
paper (19), responses to DNP-OVA in several strains of mice were shown. The time- 
course of such a response in BALB/c and BALB.K mice is shown in Fig.  1. Low levels 
of Id-460 are formed in the primary response to DNP-OVA. However, the secondary 
response is marked by a rapid and early rise in Id-460 levels, which is paralleled by a 
rapid  and  early  rise  in  total  anti-DNP  antibody.  Subsequently,  Id-460  levels  fall 
sharply and may increase again (BALB.K), whereas the anti-DNP antibody response 
reaches and maintains high levels. Thus, it would appear that Id-460 levels and anti- 
DNP levels in the serum may not be regulated in precisely the same fashion. Rather, 
there would appear to be idiotype-specific regulation of Id-460 levels in this response. 
However, serum anti-DNP antibody and Id-460 levels represent the complex outcome 
of production and catabolism; a more detailed analysis of this response was performed 
at the antibody-forming cell level. 
Transient Dominance of the Anti-DNP PFC Response by Id-460.  Because of the dramatic 
regulatory events apparent from assays of serum Id-460 levels in the secondary anti- 
DNP-OVA respone (19;  Fig.  1), we have carefully analyzed splenic PFC  for isotype 
and Id-460 according to the techniques outlined in Materials and Methods (Table I). 
Using  various  inhibitory  and  developing  antisera,  we  can  readily  identify  PFC 
producing anti-DNP of three isotypes as well as the production of Id-460  + anti-DNP 
antibody of each isotype. The results in Fig.  2 are typical of this response, and show 
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DAY  POST-IMMUNIZATION 
Fxo.  1.  BALB/cByJ and BALB.K mice were immunized  with  100 #g DNPs-OVA in alum plus 
pertussis intraperitoneally  on day 0, and boosted with 10/tg DNPs-OVA in saline intraperitoneally 
on day 21. Groups of four mice were bled, and levels of Id-460 and ofanti-DNP antibody determined 
by  radioimmunoassay.  Values  represent  geometric  means  with  standard  errors  all  <1.4.  O, 
BALB/cByJ; [--1,  BALB.K; --, Id-460; - - -, anti-DNP. 
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of this response,  BALB/c and BALB.K  (19).  Two  points are made by these experi- 
ments:  first, in both strains of mice there is an early increase in Id-460  + PFC, and in 
some  cases,  up  to  80-100%  of the  PFC  of a  given  isotype  may  be  Id-460  +.  This 
dominance  of the  splenic  PFC  response  correlates well with  the  data  obtained  by 
radioimmunoassay  of serum  Id-460.  Second,  the  dominance  of Id-460  +  PFC  is  a 
transient phenomenon, because by day 7-10 of the response, Id-460  + PFC have fallen 
to  low levels. Thus,  anti-DNP  antibody production  and  Id-460  production  are not 
regulated  in  parallel either  in  serum  or as observed with  splenic PFC.  Subsequent 
experiments confirm these results in general. Peak Id-460  + PFC responses occur early 
after boosting immunization but do not always occur on the same day from experiment 
to experiment. Id-460  + PFC (direct plus indirect PFC) usually account for 52-91% of 
anti-DNP  PFC  seen between  days 3  and  5,  whereas  minimum  percentages of these 
plaques are seen days 7 and  10. A  summary of maximum and minimum percentages 
of Id-460  + PFC in several experiments is shown in Table II, and confirms the highly 
variable nature of Id-460 expression in these responses, as well as the tendency of Id- 
460 to dominate such anti-DNP antibody responses transiently. 
The specificity of the anti-Id-460 antiserum  used  for inhibition in  the PFC  assay 
has  been  confirmed  in  several  ways.  The  transience  of  PFC  inhibition  by  itself 
demonstrates that anti-Id-460 identifies only some, and not all, anti-DNP PFC. This 
antiserum  does not  inhibit anti-PC  PFC  at  any concentration  tested  (K.  Bottomly, 
personal communication) or anti-SRBC PFC. It does not inhibit plaque formation of 
MOPC  315 myeloma cells while inhibiting the formation of MOPC  460  PFC. Thus, 
the anti-idiotypic inhibitor antiserum  reveals specific Id-460  + PFC  in the secondary 
in vivo anti-DNP response. 
Representation of Ido460 in  Various Ig Isotypes.  To test the hypothesis that regulation 1436  TRANSIENT IDIOTYPIC DOMINANCE 
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Fie.  2.  Individual spleens from: A. BALB/cByJ; B. BALB.K, were plaqued at each time point 
after boosting with DNP-OVA (day 0) for: IgM, IgG1, and IgG2a  TNP-PFC, Percent Id-460  + PFC 
was determined by inhibition of TNP-PFC  with specific anti-Id-460 antiserum at all time points 
except day 0. [--1, IgM; ~, lgGl; D, IgG2a. 
of Ig isotype production is mediated  by anti-idiotypic T  cells operating on idiotypes 
that  are selectively represented  in certain  isotypes, we have examined  the  represen- 
tation  of Id-460 as a  function of time in various isotypes during the secondary anti- 
DNP PFC response to DNP-OVA. The results of two experiments are shown in Fig. 
2. The pattern  of the response appears to be clear in that Id-460  + PFC peak first  for 
IgM PFC, then decline rapidly. Id-460 representation in IgG PFC lags slightly behind 
that  of IgM PFC. This pattern  of response has been observed in other experiments, 
but  the  maximum  Id-460 response in the various isotypes does not always occur on 
exactly the same day after boosting or represent  the same maximim percentage of the 
response.  Therefore,  compilation of the  isotype time-course data  for all experiments 
averages the highly fluctuating percentages of Id-460  + PFC early in the response and 
results in high standard errors. Individual spleens must be analyzed to obtain accurate E.  A.  DZIERZAK,  R.  W.  ROSENSTEIN,  AND  C.  A. JANEWAY, JR.  1437 
TABLE  II 
Maximum and Minimum Levels of Id-460-positive PFC during Secondary 
Anti-DNP Responses* 
Isotype of PFC 
Maximum percent  Minimum percent 
Id-460  + PFC  Id-460  ÷ PFC 
BALB/c  BALB.K  BALB/c  BALB.K 
I gM  685  85  16  6 
(32-95)  (64-98)  (0-39)  (0-14) 
IgGl  63  70  11  4 
(17-m0)  (52-91)  (0-31)  (0-13) 
IgG2a  57  81  17  11 
(41-81)  (53-100)  (0-41)  (0-20) 
* Groups of BALB/c and BALB,K mice were primed and boosted with DNP- 
OVA,  and  secondary  splenic  anti-TNP-PFC  were  measured  on  several 
different days after boosting. For each experiment  (BALB/c, seven experi- 
ments; BALB.K, three experiments), the maximum and minimum level for 
the percent  Id-460  +  PFC  was determined  for  PFC  of each  isotype tested. 
Responses of < 10  ~ PFC/spleen in any isotype were not considered, 
$ Arithmetic  mean  percent  Id-460  +  PFC  and  range  (in  parentheses)  are 
presented. 
maximum and minimum percentages of Id-460  + PFC. Table II shows the fluctuation 
and  range  of Id-460  expression  in  IgM,  IgGx,  and  IgG2a  PFC  in  seven  plaquing 
experiments with BALB/c mice and three with BALB.K mice. It is clear that Id-460 
is  represented  in  all  three  isotypes  and  that  Id~460 +  PFC  can  represent  a  major 
portion of the anti-DNP PFC response in all three isotypes. Minimum percentages of 
Id-460  + PFC for each experiment also reveal the transience of idiotypic dominance in 
each isotype. Thus, it would appear that the simplest explanation of these findings is 
that activation of an Id-460  + B cell gives rise to Id-460 + PFC forming first IgM and 
then IgG. Sometimes a late increase in Id-460  ÷ PFC is also observed. From these data 
there is no preferential association of idiotype and isotype, and we cannot confirm our 
hypothesis that  isotype is regulated via idiotype, at least in this system. The expla- 
nation  for independent  regulation  of IgM  and  IgG  responses  should  probably be 
sought elsewhere. 
Discussion 
Responses to several antigens have been shown to include expression of particular 
inherited  idiotypic determinants  (22).  In  most  systems,  these  idiotypes make  up  a 
stable proportion of the response. Thus, the response to PC in BALB/c mice is >95% 
T15-Id  +  (23,  24).  Responses  to  streptococcal  A  carbohydrate  (25)  and  to  p-azo- 
phenylarsonate (26)  in A/J mice each have 20-70% antibody bearing a major, cross- 
reactive idiotype. In contrast, certain idiotypes are found only in individual or small 
numbers of mice (27) or not at all in immune responses of normal mice (18), The only 
previous idiotype showing transient dominance of a  response are those of C57BL/6 
(28)  and BALB/c  (29)  mice to the hapten 3-nitro-4-hydroxyphenylacetyl, in which 
the primary response is dominated by antibody bearing an inherited idiotype and ?~ 
light chains, but hyperimmune antibodies are r  and idiotype negative  (29).  Id-460 
shows a transient dominance in the secondary anti-DNP response and is the predom- 
inant idiotype expressed in serum early in the response. 1438  TRANSIENT IDIOTYPIC DOMINANCE 
In this paper, the phenomenon of transient dominance of Id-460 expression during 
in  vivo anti-DNP  antibody responses in  normal mice is strikingly demonstrated  by 
measuring splenic anti-TNP PFC.  The percentage of Id-460  + PFC reaches an early 
maximum about 5 d after boosting, whereas the concentration of serum Id-460 usually 
peaks around  day  7-10.  It would  appear that  there  is  a  preferential production  of 
anti-DNP antibody bearing Id-460 early in the secondary response. The time-course 
of Id-460 expression correlates well with the time-course of action of a  second helper 
T  cell that has been observed shortly after boosting in adoptive transfer experiments 
and  is  missing in  mice treated  with  anti-# chain  antibody in  the  DNP  system  (4). 
Such  treatment  has been shown  to deplete  idiotype-specific helper T  cells in  other 
experiments (8). We would propose that the transient expression of Id-460 reflects the 
early action of such Ig-dependent helper T  cells. This suggests the presence of some 
type of idiotype-anti-idiotype interaction and the existence of an Id-460 recognizing 
helper T  cell.  Furthermore,  we have proposed  (15)  that  this same cell  also induces 
suppressor T  cells via the heavy-chain variable-region-restricted pathway defined by 
Eardley et al. (30), and thus its action may be twofold. First, it induces Id-460  + B cells 
selectively, and  second,  it  activates suppressor T  cells  via an  idiotype-anti-idiotype 
pathway potentially leading to the inactivation  of such  Id-460-bearing B cells. The 
result of such a complex interaction would be the transient idiotypic dominance that 
was in  fact observed. The validity of this  interpretation  is now being tested  at  the 
cellular level. 
The  data  presented  also  show  that  Id-460  is  not  restricted  in  its  expression  to 
particular isotypes, although IgM and IgGa are the major isotypes represented. Id-460 
is  found  associated essentially equally  in  the  three  isotypes, IgM, IgG1, and  IgG2a, 
that we have studied at the PFC level. We have also found parallel expression of Id- 
460  levels by radioimmunoassay and  IgE anti-DNP  antibody by passive cutaneous 
anaphylaxis. In preliminary experiments we find that some, but not all, of the IgE in 
this response can be neutralized by anti-Id-460 (unpublished results). 
Because Id-460 expression is not restricted to particular isotypes, idiotypic regulation 
cannot  by itself account  for isotypic regulation  in  this system.  Rather,  the  pattern 
observed is one in which cycling occurs. Id-460  + PFC switch from IgM to IgG and are 
followed by a  wave of Id-460- PFC,  again switching from IgM to IgG. Late in  the 
response, as the total number of anti-DNP PFC decreases, the proportion of Id-460  + 
PFC are often observed to increase. We have no evidence to suggest that the Id-460- 
PFC arise from the Id-460  + population.  Instead, it would appear at present that Id- 
460 + PFC are active early in the response and can be regulated independently of the 
Id-460- PFC or the total anti-DNP PFC response. 
These results would appear to conflict with those obtained previously both in these 
laboratories  (18)  and  those of Bona  and  Paul  (31)  and  Bona  and  co-workers  (32). 
There are several possible explanations  for these differences.  First,  the antigen  and 
schedule of immunization was different;  Zeldis et al.  (18)  used DNP-bovine gamma 
globulin  in  CFA, and measured serum Id-460 at  day  10 of the secondary response, 
whereas Bona and Paul (31) and Bona et al. (32) used TNP on various T-independent 
carriers  in  vivo or  in  vitro,  and  measured  PFC  at  day 3  of the  primary response. 
Given  the  extreme  variability  in  Id-460  expression  we  have  observed,  it  is  not 
surprising that such changes in protocol might influence the percent Id-460  + antibody 
detected. However, the more likely explanation for the differences between the present E.  A.  DZIERZAK, R. W.  ROSENSTEIN, AND C.  A. JANEWAY, JR.  1439 
results and those of Bona and Paul (31)  and Bona et al. (32)  lies in the anti-idiotypic 
reagents used. Bona et al. used mouse anti-Id-460, which is not characterized in terms 
of light-chain genetics or binding-site specificity, whereas we used a site-specific rabbit 
anti-Id-460 that detects a  determinant, the expression of which is regulated by genes 
mapping to both  Igh-V ang IgK-V. Even  more significant  is  the  finding  2 that  our 
anti-Id-460 detects Id-460 in the serum of all strains of normal mice thus far tested, 
and in significant amounts. Thus, it is unlikely that mouse anti-Id-460 would detect 
the determinant(s)  on MOPC 460 measured in our studies. Indeed, one might almost 
predict  from the serology alone that  the results in these studies would differ. None- 
theless, all three sets of studies agree in finding that anti-DNP antibody can express 
significant amounts of Id-460 in BALB/c mice. 
We  are  currently  studying  the  cellular,  genetic,  and  environmental  factors  that 
contribute  to this  transient  idiotypic dominance.  Besides idiotype-specific helper T 
cells, we are testing the role of the Id-460-specific suppressor T  cell described by Bona 
and Paul (31)  as regulating in vitro anti-TNP responses in our system. Because of the 
great variability of Id-460 expression, characterization of this response has proven to 
be more difficult than with other more stably dominated responses. One critical factor 
in  dominant  expression of Id-460 may be the  finding of large amounts of Id-460  +, 
non-DNP-binding material in serum from nonimmune mice (33).2 This material may 
play a role in establishing the idiotypic cell interactions for the Id-460 response. 
Summary 
After immunization of mice with 2,4-dinitrophenyl-ovalbumin (DNP-OVA), it was 
shown previously that strains having Igh-V  a genes and able to express light chains of 
the V~ 1 group produce high levels of anti-DNP antibody bearing an idiotype (Id-460) 
associated with  the combining site of the  BALB/c  DNP-binding  myeloma protein 
MOPC 460. Expression of Id-460 in serum is transient; Id-460 levels peak early in the 
response and are regulated independently of total anti-DNP antibody. In this paper, 
the transient dominance of Id-460 expression has been confirmed at the cellular level 
by inhibition of splenic anti-DNP plaque-forming cells (PFC) with rabbit anti-Id-460 
antiserum.  Id-460  ÷  PFC  can  account  for  52-91%  of  anti-DNP  PFC  early  after 
secondary  challenge  with  DNP-OVA.  Furthermore,  Id-460  is  represented  at  these 
high levels in IgM, IgG1, and IgG2a, the three isotypes tested in the PFC assay, as well 
as in IgE, as tested by passive cutaneous anaphylaxis. Thus, there is no preferential 
association of Id-460 with a given isotype. We conclude from these studies that Id-460 
is a dominant idiotype in the anti-DNP antibody response of BALB/c mice to DNP- 
OVA.  This  dominance  is  expressed  transiently  and  is  independent  of isotype.  A 
further  conclusion  from  these  studies  is  that  regulation  of  isotype  expression  is 
independent of the regulation of idiotype expression in this system. We would suggest 
that regulation of Id-460 expression involves Ig-dependent helper T  cells specific for 
Id-460 that  induce Id-460  ÷ B cells and also activate suppressor T  cells, both events 
occurring via idiotype-anti-idiotype interactions. 
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